integrator_log

TL3 Regular · Rotterdam, NL

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 2 February 2025 · last posted 11h · groups: pharmacists, translators

128 posts, newest first. Showing up to 150.

Cost versus information: making the trade-off explicitly Replied, post #7 · Analytics › Home & field testing · 27 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #114 · Analytics › Home & field testing · 23 Jul 2026 · 0 likes post #113 answers the question as asked. The question underneath it is different. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #126 · Evidence › Journal club · 22 Jul 2026 · 27 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #92 · Analytics › Method validation · 16 Jul 2026 · 15 likes post #91 answers the question as asked. The question underneath it is different. Why two laboratories may disagree: after validating the same method, they may still…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #88 · Sourcing › Independent verification · 13 Jul 2026 · 2 likes Worth separating two things that post #84 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #89 · Compounds › Repair & healing peptides · 12 Jul 2026 · 0 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
Coming back to: Telehealth prescribing models in the US Replied, post #12 · Regional › North America · 11 Jul 2026 · 0 likes Picking up post #9: that is the part I would want checked first. Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #10 · Clinical › Comorbidities · 9 Jul 2026 · 2 likes Coming back to post #8, because the follow-up matters more than the original answer. Interactions between comorbidities: diabetes and kidney disease together change the…
Aggregate verification data across the directory, with caveats Replied, post #36 · Sourcing › Independent verification · 9 Jul 2026 · 4 likes This follows post #33 rather than contradicting it. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #53 · Practice › Administration · 7 Jul 2026 · 14 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
What a reversed-phase purity number actually is Replied, post #26 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
Athletes in weight-category sports: a different risk calculus Replied, post #13 · Clinical › Special populations · 5 Jul 2026 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Hepatic impairment: less is known about dosing in significant liver disease than in…
Common supplements people ask about, assessed one at a time Replied, post #10 · Practice › Interactions · 4 Jul 2026 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #57 · Compounds › Oral incretins · 24 Jun 2026 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
Second pass at: Programming during a large energy deficit Replied, post #40 · Nutrition & Training › Resistance training · 22 Jun 2026 · 1 like post #39 answers the question as asked. The question underneath it is different. Cardio and resistance: the interaction between energy-intense cardiovascular training…
Request: a per-category review queue Replied, post #48 · Meta › Feature requests · 20 Jun 2026 · 2 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
An appeal that succeeded, with the letter structure — the long version Replied, post #108 · Access › Insurance & coverage · 16 Jun 2026 · 19 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
What changed in 2026, by region — does this still hold? Replied, post #15 · Access › International · 13 Jun 2026 · 0 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
Racemisation and why it is invisible to a mass measurement Replied, post #78 · Analytics › Impurities & related substances · 13 Jun 2026 · 18 likes This follows post #75 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Run-in periods and the population they select Replied, post #134 · Evidence › Trials · 11 Jun 2026 · 5 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
A critique that turned out to be unfair, retracted by its author Replied, post #10 · Evidence › Study critique · 10 Jun 2026 · 18 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
Comparing prices across jurisdictions without misleading yourself Replied, post #58 · Access › Pricing · 9 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
What I would want from a home test that does not exist yet — what changed since Replied, post #46 · Analytics › Home & field testing · 7 Jun 2026 · 15 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
Pooling trials with different estimands Replied, post #11 · Evidence › Meta-analyses · 7 Jun 2026 · 5 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
Official shortage notices and what they authorise Replied, post #89 · Access › Shortages · 5 Jun 2026 · 11 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Second pass at: I joined for one answer and stayed for a year — what changed my mind Replied, post #5 · Start Here › Welcome · 5 Jun 2026 · 25 likes I read post #3 twice before replying, because I had assumed the opposite. Welcome. The orientation materials are pinned at the top of this category and they take about…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #95 · Compounds › Tirzepatide · 27 May 2026 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #62 · Evidence › Preprints · 25 May 2026 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Endotoxin and why it is a separate question from purity — what changed since Replied, post #27 · Analytics › Impurities & related substances · 25 May 2026 · 1 like Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
Prescription portability between countries Replied, post #39 · Access › International · 21 May 2026 · 12 likes post #38 is right about the mechanism and I think understates the practical bit. Insurance and coverage: coverage decisions are national. A compound approved in one…
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #15 · Analytics › Mass spectrometry · 17 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #94 · Research Methods › Statistics · 3 May 2026 · 0 likes Picking up post #91: that is the part I would want checked first. Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one…
A widely repeated interaction claim that turns out to be unsupported Replied, post #51 · Practice › Interactions · 1 May 2026 · 6 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
An 18-month record including the parts that went badly Replied, post #7 · Outcomes › Progress reports · 30 Apr 2026 · 0 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
How to ask about something you suspect is a bad idea Replied, post #82 · Start Here › How to Ask · 28 Apr 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #88 · Practice › Interactions · 16 Apr 2026 · 2 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
Micro-titration: a disputed topic, argued properly Replied, post #60 · Practice › Dosing & titration · 14 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #21 · Practice › Dosing & titration · 5 Apr 2026 · 1 like Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
[2026 update] Composite endpoints and the component doing the work Replied, post #51 · Evidence › Trials · 31 Mar 2026 · 30 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Blind submission and why it changes minds — the long version Replied, post #2 · Sourcing › Independent verification · 28 Mar 2026 · 3 likes On the opening post — agreed on the reasoning, with one qualification. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples.…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #23 · Analytics › HPLC & UHPLC · 27 Mar 2026 · 3 likes Picking up post #20: that is the part I would want checked first. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species'…
Type 2 diabetes and the largest part of the evidence base Replied, post #43 · Clinical › Comorbidities · 25 Mar 2026 · 1 like Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #68 · Analytics › Mass spectrometry · 14 Mar 2026 · 5 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
Why chargeback is not the safety net people assume Replied, post #4 · Sourcing › Payments · 11 Mar 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #101 · Evidence › Study critique · 2 Mar 2026 · 4 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
Angle of injection and whether 90 degrees is always right Replied, post #107 · Practice › Administration · 26 Feb 2026 · 16 likes Worth separating two things that post #103 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Preprint servers and what screening they do Replied, post #69 · Evidence › Preprints · 26 Feb 2026 · 9 likes I read post #67 twice before replying, because I had assumed the opposite. Check whether it was later published: searching for the preprint's first author and keywords…
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #9 · Evidence › Journal club · 24 Feb 2026 · 10 likes Worth separating two things that post #5 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #26 · Practice › Storage & stability · 21 Feb 2026 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
[2026 update] Composite endpoints and the component doing the work Replied, post #8 · Evidence › Trials · 20 Feb 2026 · 26 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #59 · Analytics › Impurities & related substances · 18 Feb 2026 · 3 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #50 · Clinical › Bloodwork · 14 Feb 2026 · 3 likes post #49 answers the question as asked. The question underneath it is different. Reference intervals: constructed to contain the central 95% of a reference population,…
Liver enzymes drifting down and what that usually means Replied, post #56 · Clinical › Bloodwork · 13 Feb 2026 · 4 likes Coming back to post #54, because the follow-up matters more than the original answer. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel.…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #25 · Sourcing › Independent verification · 12 Feb 2026 · 1 like Worth separating two things that post #21 runs together. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services…
Interpreting a result that disagrees with the supplier's certificate Replied, post #117 · Sourcing › Independent verification · 11 Feb 2026 · 29 likes Worth separating two things that post #113 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #38 · Evidence › Study critique · 9 Feb 2026 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #27 · Evidence › Study critique · 4 Feb 2026 · 29 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #23 · Evidence › Trials · 30 Jan 2026 · 16 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
What I would record differently if I started again — the long version Replied, post #24 · Outcomes › Progress reports · 20 Jan 2026 · 25 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #54 · Regional › UK & Ireland · 10 Jan 2026 · 9 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
A partial dose because the pen emptied mid-injection Replied, post #90 · Practice › Administration · 10 Jan 2026 · 17 likes This follows post #87 rather than contradicting it. A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #43 · Practice › Storage & stability · 30 Dec 2025 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 21 Dec 2025 · 3 likes Worth separating two things that post #2 runs together. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through…
Research-use-only labelling: what it means and what it does not Replied, post #72 · Sourcing › Regulatory · 13 Dec 2025 · 0 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
About the Dosing & titration category Replied, post #3 · Practice › Dosing & titration · 25 Nov 2025 · 12 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #36 · Compounds › Tirzepatide · 10 Nov 2025 · 0 likes Coming back to post #34, because the follow-up matters more than the original answer. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose…
Second pass at: Programming during a large energy deficit Replied, post #63 · Nutrition & Training › Resistance training · 1 Nov 2025 · 29 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
A 40-week log with the measurement method stated Replied, post #56 · Outcomes › Progress reports · 23 Oct 2025 · 3 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #57 · Compounds › Tirzepatide · 21 Oct 2025 · 13 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Payment mechanics and the recovery options that do not exist Replied, post #31 · Sourcing › Payments · 20 Oct 2025 · 4 likes This follows post #28 rather than contradicting it. Refund policy before ordering: ask what the policy is if you receive damaged material or if the order is incorrect.…
Sleep tracking data and its considerable limitations Replied, post #22 · Wellbeing › Sleep · 17 Oct 2025 · 1 like Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 0 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
Second pass at: The mass-error checker and its intended scope Replied, post #28 · Data & Tools › Calculators · 30 Sep 2025 · 33 likes On post #24 — agreed on the reasoning, with one qualification. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…
Hypertension improvement and when medication needs revisiting Replied, post #39 · Clinical › Comorbidities · 3 Sep 2025 · 13 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
Pinch or no pinch, and how needle length changes the answer Replied, post #27 · Practice › Administration · 20 Aug 2025 · 8 likes I read post #25 twice before replying, because I had assumed the opposite. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #85 · Data & Tools › Calculators · 17 Aug 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #72 · Evidence › Trials · 11 Aug 2025 · 23 likes Picking up post #69: that is the part I would want checked first. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #58 · Clinical › Special populations · 11 Aug 2025 · 22 likes post #57 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Publishing an inconvenient result: a case study Replied, post #60 · Sourcing › Independent verification · 3 Aug 2025 · 2 likes post #59 answers the question as asked. The question underneath it is different. How to submit a sample: contact the service directly. They will provide instructions on…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #17 · Compounds › Tirzepatide · 21 Jul 2025 · 9 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
A field-by-field walk through a certificate of analysis Replied, post #78 · Analytics › COA interpretation · 16 Jul 2025 · 13 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
A field-by-field walk through a certificate of analysis Replied, post #41 · Analytics › COA interpretation · 15 Jul 2025 · 4 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #78 · Compounds › Retatrutide · 12 Jul 2025 · 0 likes Picking up post #75: that is the part I would want checked first. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3…
About the Side effects category Replied, post #5 · Practice › Side effects · 11 Jul 2025 · 8 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #76 · Clinical › Comorbidities · 27 Jun 2025 · 17 likes Worth separating two things that post #72 runs together. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #37 · Meta › Wiki maintenance · 18 Jun 2025 · 0 likes post #36 is right about the mechanism and I think understates the practical bit. Orphaned pages: if a page has no incoming links and is not reachable from navigation,…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #21 · Sourcing › Regulatory · 16 Jun 2025 · 8 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
Half-life, steady state, and accumulation worked through Replied, post #105 · Pharmacology › Pharmacokinetics · 12 Jun 2025 · 0 likes post #104 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Reading a chromatogram someone posted without axes Replied, post #44 · Analytics › HPLC & UHPLC · 11 Jun 2025 · 0 likes Picking up post #41: that is the part I would want checked first. Method validation is the demonstration that a method can separate the compound from its degradation…
Coming back to: Getting a referral rather than a refusal Replied, post #35 · Clinical › Prescriber conversations · 5 Jun 2025 · 6 likes On post #31 — agreed on the reasoning, with one qualification. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence…
Reading a trial's population section before its results — does this still hold? Replied, post #72 · Evidence › Trials · 5 May 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Anxiety in the first weeks: drug, situation, or both Replied, post #76 · Wellbeing › Mental health · 17 Apr 2025 · 11 likes This follows post #73 rather than contradicting it. Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and…
Retatrutide dose escalation in the published trials Replied, post #113 · Compounds › Retatrutide · 10 Apr 2025 · 0 likes post #112 is right about the mechanism and I think understates the practical bit. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
A promotion I argued against, and why I lost Replied, post #143 · Documentation › Doc review · 22 Mar 2025 · 12 likes Coming back to post #141, because the follow-up matters more than the original answer. Citation checking: if a maintained page cites a paper, the citation should match…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #106 · Compounds › Semaglutide · 18 Mar 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #3 · Compounds › Repair & healing peptides · 7 Mar 2025 · 3 likes post #2 is right about the mechanism and I think understates the practical bit. Oral versus injected administration claims for BPC-157: the preclinical work studied…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #21 · Evidence › Journal club · 3 Mar 2025 · 30 likes Picking up post #18: that is the part I would want checked first. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg…
Reading a chromatogram someone posted without axes Replied, post #7 · Analytics › HPLC & UHPLC · 1 Mar 2025 · 8 likes On post #3 — agreed on the reasoning, with one qualification. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher…
Consistent declarations and why they matter more than clever ones Replied, post #104 · Sourcing › Logistics · 28 Feb 2025 · 23 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #5 · Sourcing › Regulatory · 27 Feb 2025 · 9 likes Coming back to post #3, because the follow-up matters more than the original answer. Preclinical versus clinical: compounds with strong preclinical data can fail in…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #139 · Evidence › Journal club · 24 Feb 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #34 · Devices › Syringes & needles · 24 Feb 2025 · 8 likes This follows post #31 rather than contradicting it. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #44 · Evidence › Journal club · 19 Feb 2025 · 24 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #46 · Practice › Side effects · 31 Jan 2025 · 3 likes Worth separating two things that post #42 runs together. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #33 · Clinical › Special populations · 31 Jan 2025 · 7 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
Canadian access and provincial variation Replied, post #24 · Regional › North America · 27 Jan 2025 · 0 likes On post #20 — agreed on the reasoning, with one qualification. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries'…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #60 · Data & Tools › Calculators · 21 Jan 2025 · 0 likes I read post #58 twice before replying, because I had assumed the opposite. Dose equivalence calculator: compounds have different potencies. The calculator is provided…
What changed in 2026, by region Replied, post #73 · Access › International · 12 Jan 2025 · 10 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #119 · Compounds › Oral incretins · 28 Dec 2024 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
[2026 update] New subcategory: rationale and scope Replied, post #100 · Meta › Announcements · 28 Dec 2024 · 1 like Coming back to post #98, because the follow-up matters more than the original answer. RSS: if you prefer to receive announcements by feed rather than visiting the site,…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #15 · Compounds › Oral incretins · 25 Dec 2024 · 16 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
Building a sensible monitoring schedule with your prescriber Replied, post #107 · Clinical › Bloodwork · 23 Dec 2024 · 0 likes post #106 answers the question as asked. The question underneath it is different. Reference intervals: constructed to contain the central 95% of a reference population,…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #66 · Compounds › Semaglutide · 19 Dec 2024 · 17 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
Isotonicity and what happens when you get it wrong Replied, post #3 · Pharmacology › Formulation chemistry · 18 Dec 2024 · 21 likes post #2 answers the question as asked. The question underneath it is different. Lyophilisation and reconstitution: the powder is stable for extended periods if kept…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #6 · Devices › Syringes & needles · 2 Dec 2024 · 12 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
Coming back to: Cost per delivered dose, which is the number that matters Started this topic · Access › Pricing · 1 Dec 2024 · 11 likes On the subject in the title: Cost per delivered dose, which is the number that matters Working notes rather than a conclusion. Documenting an access outcome, dated,…
When "no data" is the complete and final answer Replied, post #25 · Compounds › Other compounds · 21 Nov 2024 · 12 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #114 · Compounds › Other compounds · 13 Nov 2024 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #144 · Clinical › Bloodwork · 26 Oct 2024 · 0 likes Worth separating two things that post #140 runs together. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #90 · Practice › Dosing & titration · 25 Oct 2024 · 3 likes This follows post #87 rather than contradicting it. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
Reporting a discrepancy without making an allegation Replied, post #90 · Sourcing › Vendor reports · 24 Sep 2024 · 1 like Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #4 · Clinical › Bloodwork · 1 Sep 2024 · 0 likes post #2 answers the question as asked. The question underneath it is different. Biological variation: the person-to-person variation in a biomarker for a healthy person…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #11 · Practice › Side effects · 30 Aug 2024 · 1 like Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #94 · Compounds › Retatrutide · 22 Jul 2024 · 2 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Oral contraceptives and delayed emptying: what the data shows Replied, post #68 · Practice › Interactions · 18 Jul 2024 · 3 likes On post #64 — agreed on the reasoning, with one qualification. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be…
The topic list is dense — is that deliberate? Replied, post #5 · Meta › Site feedback · 16 Jul 2024 · 7 likes Search and findability: if you searched for something and did not find it, report what you searched for and what you expected to find. That helps improve indexing and…
Cold packs, phase-change material, and what survives ten days Replied, post #83 · Sourcing › Logistics · 8 Jul 2024 · 17 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
Assessing a warm arrival: the decision process — one year on Replied, post #43 · Sourcing › Logistics · 30 May 2024 · 2 likes On post #39 — agreed on the reasoning, with one qualification. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that…